MISSISSAUGA, ON, June 7 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ:VSGN - News; TSX:VAS - News), a leader in the research and commercial development of technologies targeting the chronic inflammation underlying cardiovascular and neurological disease, today announced that its President and Chief Executive Officer, David Elsley, will present a Company overview at the Needham & Company Fifth Annual Biotechnology and Medical Technology Conference at the New York Palace Hotel at 11:00 a.m. Eastern Time on Wednesday, June 14, 2006 in New York City.
